A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks

Journal of Drugs in Dermatology

Volumn 11, Issue 3, 2012, Pages 333-339

  Chang, Anne Lynn S ^a   Alora Palli, Maria ^b   Lima, Xinaida T ^b   Chang, Tiffany C ^a   Cheng, Carol ^b   Chung, Connie M ^b   Amir, Omar ^a   Kimball, Alexa B ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN PHOSPHATE PLUS RETINOIC ACID; PLACEBO;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTACT DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; EDEMA; ERYTHEMA; FACE DISORDER; FACE SCALING; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPULE; PHYSICIAN; PUSTULE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; TELANGIECTASIA; TOPICAL TREATMENT; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; GELS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; ROSACEA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRETINOIN;

EID: 84858649019     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wolff K, Johnson RA, Suurmond D. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. New York: McGraw-Hill; 2005, p. 8.
2. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499-512.
3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J am Acad Dermatol. 2002;46(4):584-587.
4. Del Rosso JQ. Anti-inflammatory dose doxycycline in the treatment of rosacea. J Drugs Dermatol. 2009;8(7):664 -668.
5. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol. 1986;25(10):660-663. (Pubitemid 17210593)
6. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994;130(3):319-324. (Pubitemid 24107870)
7. Klingman LH, Sapadin AN, Schwartz E. Peeling agents and irritants, unlike tretinoin, do not stimulate collagen synthesis in the photoaged hairless mouse. Arch Dermatol Res. 1996;288(10):615-620. (Pubitemid 26335338)
8. Voorhees JJ. Clinical effects of long-term therapy with tropical tretinoin and cellular mode of action. J Int Med Res. 1990;18(suppl 3):26C-28C. (Pubitemid 20236560)
9. Diaz BV, Lenoir MC, Ladoux A, et al. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem. 2000;275:642-650. (Pubitemid 30039029)
10. Braathen LR. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris. Scand J Infect Dis Suppl. 1984;43:71-75. (Pubitemid 15147083)
11. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993;32:65-67. (Pubitemid 23042909)
12. Wilkin J, Dahl M, Detmar, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907-912. (Pubitemid 38685771)
13. Nicholson K, Abramova L, Chren M, et al. A pilot quality of life instrument for acne rosacea. J Am Acad Dermatol. 2007; 57:213-221. (Pubitemid 47053981)
14. Van Auuren EJ, Graber MA, Hollis S, et al. Interventions for rosacea. Cochrane Database Syst Rev. 20(3):CD003262. 2005; Jul 20.
15. Tan JKL, Girard C, Krol A, et al. Randomized placebo-controlled trial of metronidazole 1% cream with sunscreen SPF 15 in the treatment of rosacea. J Cutan Med Surg. 2002;6(6):529-534. (Pubitemid 36091497)